|
Indian Pediatr 2017;54: 969-970 |
|
Therapeutic Hypothermia for Neonatal
Encephalopathy in Indian Neonatal Units: A Survey of National
Practices
|
Manigandan Chandrasekaran, Ravi Swamy, #Siddarth
Ramji, $Seetha Shankaran and *Sudhin Thayyil
Centre for Perinatal Neuroscience, Department of
Pediatrics, Imperial College London, UK;
#Department of Neonatology,
Maulana Azad Medical College, New Delhi, India; and
$Department of Neonatal Perinatal Medicine,
Wayne State University, USA.
Email:
[email protected]
|
This cross-sectional web-based survey
suggests that cooling therapy is offered as standard of care for babies
with neonatal encephalopathy in 10/25 (40%) of public and 37/68 (51%) of
private level 2 or 3 neonatal units in India. 25 (53%) used locally
improvised cooling methods, and the cooling practices differed from
established protocols in high-income countries.
Key words: Asphyxia,
Hypoxic ischemic encephalopathy, Practices, Treatment, low- and
middle-income countries
|
Therapeutic hypothermia is now the standard of care
treatment for neonatal encephalopathy in high-income countries [1].
Although all major cooling trials so far have been conducted in such
settings, anecdotal evidence suggests that therapeutic hypothermia is
increasingly used in many low- and middle-income countries (LMIC),
despite a lack of adequate safety and efficacy data [2]. The dangers of
clinical adoption without robust local evidence have been recently
highlighted with several therapeutic interventions such as antenatal
corticosteroids [3, 4], and fluid bolus for septic shock, where a
standard of care therapy in high-income countries was shown to be
harmful in LMIC settings [4]. We wanted to examine if therapeutic
hypothermia was being offered as a standard of care in Indian neonatal
units, and if so, whether the established cooling protocols from
high-income countries were being adhered to.
We identified potential participants using the online
listing of all level 2 (a and b) and 3 neonatal intensive care units in
hospitals across India on the National Neonatology Forum database [5].
We formulated a 10-part questionnaire using multiple choice or
dichotomous questions (www.surveymonkey.com), and e-mailed
an individualized link to the survey to the lead clinicians of the
eligible centers, in May 2015. We contacted the lead clinician over
telephone if there was no response to multiple e-mail reminders. We
exported the responses to Microsoft Excel, and calculated the
frequencies and percentages for all categorical responses. We clarified
any data queries over telephone with the participants.
We contacted a total of 120 neonatal units, of which
93 (78%) responded. The majority (91%) of respondents were of consultant
grade. Of those who responded, 68 (73%) units were in the private or
semi-private sector (where patients had to pay full or partial treatment
costs), and 25 (27%) were in the public sector (offering free health
care to patients). Annual median neonatal encephalopathy admissions in
public and private sector hospitals were 250 and 31, respectively.
Forty-seven (51%) units offered cooling therapy in
clinical practice, and all of these units were located in areas of low
infant mortality (Web Fig. 1). A further 41
(44%) hospitals wanted to offer cooling therapy, but were unable to, due
to a lack of cooling devices and trained staff. Although five (5.4%)
wanted to see more rigorous research data from clinical trials before
routine clinical use, none of the responders felt that cooling therapy
was unsafe or ineffective (Table I).
TABLE I Practice of Cooling Therapy in Selected Tertiary and Secondary Care Indian Neonatal Units
|
Public (n=10) |
Private (n=37) |
|
No (%) |
No (%) |
Criteria for cooling |
|
|
Clinical
|
8 (80) |
22 (60) |
Clinical and aEEG |
0 |
1 (3) |
Clinical and blood gas |
2 (20) |
12 (32) |
Clinical, blood gas and aEEG |
0 |
2 (5) |
Cooling devices |
|
|
Approved* |
9 (90) |
13 (35) |
Indigenous** |
1 (10) |
24 (65) |
Initiation of cooling# |
|
|
Within 6 hours
|
10 (100) |
28 (76) |
Upto 12 hours
|
0
|
7 (19) |
Upto 24 hours
|
0
|
2 (5) |
Sedation during cooling |
|
|
Intravenous
|
6 (60) |
20 (54) |
Oral
|
2 (20) |
2 (5) |
None |
2 (20) |
15 (41) |
Neuroimaging
|
|
|
Cranial ultrasound |
8 (80) |
28 (76) |
Computerized tomography |
1 (10) |
2 (5) |
Magnetic resonance imaging |
8 (80) |
32 (86) |
*Tecotherm or Blanketrol® ;**Phase change material, ice, water bottles, saline bottles and air conditioning: #after birth. |
Our survey suggests that despite a lack of local
evidence [2], cooling therapy is now widely used both in public and
private sector hospitals in all major Indian cities. However, the
cooling practices varied widely from high-income country guidelines [1],
particularly in private sector hospitals. As with any survey, the data
presented here is subject to recall bias of the respondents as there are
no prospective cooling registries in India. Hence, we made no attempt to
collect mortality or morbidity data.
Many of these current cooling practices (lack of
sedation, delayed cooling therapy beyond 6 hours of age), and locally
improvised cooling methods without reliable core temperature control,
may be ineffective, and potentially harmful [4]. Extreme cooling methods
using ice and frozen gel packs may result in marked fluctuations in core
temperature without close nursing monitoring. On the other hand, milder
cooling methods using phase change materials, fans, water bottles, or
air-conditioning may not result in adequate hypothermia [4].
Furthermore, lower thresholds of inclusion criteria may unnecessarily
expose babies without encephalopathy or with mild encephalopathy to
cooling therapy.
Deviation from the evidence base established by
rigorous randomized controlled trials is not uncommon when a new therapy
is introduced into clinical practice, with clinicians becoming
increasingly comfortable with the new therapy. A recent Australian
survey reported almost half of the cooling in babies in New South Wales
deviated from accepted protocols [6]. However, clinicians in LMIC need
to recognize that the evidence base for the routine use of cooling
therapy in these settings is not yet available, and further research is
required to establish this. The success of the cooling story appears to
be so overwhelming that none of the neonatal centers in India expressed
concerns about safety or ineffectiveness, despite a lack of any
published long-term outcome studies of cooling therapy from low- and
middle-income countries.
Whilst more research data are awaited from rigorous
randomized controlled trials of cooling therapy in LMIC, it may be
prudent to develop national guidelines and training programs on cooling
therapy for routine clinical practice in these countries.
Acknowledgements: Professor Kumutha Kumaraswami (Saveetha
Medical College, Tamil Nadu) for contacting neonatal units and
encouraging them to participate in the survey, and Subhadeep Paul
(Department of Statistics, University of Illinois, USA) for generating
the heat map of infants mortality rates.
Contributors: MC designed the study,
collected and analysed the data along with RS and prepared the initial
draft of the manuscript. SS and SR interpreted the data and developed
the manuscript. ST conceived the idea, designed the study, interpreted
the data and developed the manuscript. All authors approved the final
version of manuscript for submission.
Funding: This research was supported by the
National Institute for Health Research (NIHR) Biomedical Research Centre
based at Imperial College Healthcare NHS Trust and Imperial College
London. The views expressed are those of the authors and not necessarily
those of the NHS, the NIHR or the Department of Health.
Competing interests: None stated.
References
1. National Institute for Health and Care Excellence.
Therapeutic Hypothermia With Intracorporeal Temperature Monitoring for
Hypoxic Perinatal Brain Injury. Available from:
https://www.nice.org.uk/guidance/ipg347. Accessed April 17, 2017.
2. Pauliah SS, Shankaran S, Wade A, Cady EB, Thayyil
S. Therapeutic hypothermia for neonatal encephalopathy in low- and
middle-income countries: a systematic review and meta-analysis. PLoS
One. 2013;8:e58834.
3. Althabe F, Belizán JM, McClure EM, Hemingway-Foday
J, Berrueta M, Mazzoni A, et al. A population-based, multifaceted
strategy to implement antenatal corticosteroid treatment versus standard
care for the reduction of neonatal mortality due to preterm birth in
low-income and middle-income countries: The ACT cluster-randomised
trial. Lancet. 2015;385:629-39.
4. Montaldo P, Pauliah SS, Lally PJ, Olson L, Thayyil
S. Cooling in a low-resource environment: Lost in translation. Semin
Fetal Neonatal Med. 2015;20:72-9.
5. National Neonatology Forum Accredited Centres.
Available from:
http://www.nnfi.org/images/pdf/accreditation/NNFAccreditationAssessmentUndertakenas
perRevisedLevelIIGuidelines.pdf. Accessed April 17, 2017.
6. Mehta S, Joshi A, Bajuk B, Badawi N, McIntyre S, Lui K, et al.
Eligibility criteria for therapeutic hypothermia: From trials to
clinical practice. J Pediatr Child Health. 2017;53:295-300.
|
|
|
|